Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term open-label teduglutide in parenteral nutrition-dependent short bowel syndrome
2009-011679-65Phase 3Completed
- Sponsor
- NPS Pharmaceuticals, Inc.
- Start
- Dec 2009
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of teduglutide in short bowel syndrome (SBS), sponsored by NPS Pharmaceuticals, Inc. Primary endpoint: Parenteral/IV nutrition volume. Started Dec 2009; status: completed.
02
Drugs
teduglutide
03
Conditions
short bowel syndrome (SBS)
Beyond the preview
Go deeper on 2009-011679-65.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011679-65.